Search results
Showing 51 to 100 of 636 results for diabetes
This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
NICE has developed a medtech innovation briefing (MIB) on d-Nav insulin management app for type 2 diabetes .
foot problems in a timely manner, whilst ensuring that all people with diabetes received an annual foot assessment. Objectives: To train...
This guideline covers how local communities, with support from local organisations and networks, can help prevent people from becoming overweight or obese or help them lose weight. It aims to support sustainable and community-wide action to achieve this.
support primary care diabetes teams in working with patients to optimise prescribing through implementation of NICE guideline for...
November 2018 Spend on diabetes prescribing; in particular glucagon like peptide 1 (GLP-1) mimetics within
Psychosis and schizophrenia in adults: prevention and management (CG178)
This guideline covers recognising and managing psychosis and schizophrenia in adults. It aims to improve care through early recognition and treatment, and by focusing on long-term recovery. It also recommends checking for coexisting health problems and providing support for family members and carers.
Admission rates for people with diabetes due to complications associated with diabetes
Admission rates for people with diabetes due to complications associated with diabetes Subject(s): Diabetes...
NICE has developed a medtech innovation briefing (MIB) on PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes .
This quality standard covers assessing and managing obesity in adults, young people and children, including referral for specialist care and bariatric (weight loss) surgery. It includes people who are obese and have, or are at risk of, other medical conditions. It describes high-quality care in priority areas for improvement.
View quality statements for QS127Show all sections
Sections for QS127
- Quality statements
- Quality statement 1: Informing people of their BMI
- Quality statement 2: Discussion on the choice of interventions
- Quality statement 3: Referring children and young people for specialist care
- Quality statement 4: Referring adults with type 2 diabetes for bariatric surgery assessment
- Quality statement 5: Referring adults for bariatric surgery assessment
- Quality statement 6: Follow-up care after bariatric surgery
- Quality statement 7: Nutritional monitoring after discharge from the bariatric surgery service
This guideline covers care for adults (aged 18 and over) having elective or emergency surgery, including dental surgery. It covers all phases of perioperative care, from the time people are booked for surgery until they are discharged afterward. The guideline includes recommendations on preparing for surgery, keeping people safe during surgery and pain relief during recovery.
NICE-recommended 9 key care processes, or whose care processes indicated poor Type 2 Diabetes (T2D) control. The project aimed to reduce...
This guideline covers exercise referral schemes for people aged 19 and older, in particular, those who are inactive or sedentary. The aim is to encourage people to be physically active.
Obesity in adults: prevention and lifestyle weight management programmes (QS111)
This quality standard covers preventing adults (aged 18 and over) from becoming overweight or obese. It includes strategies to increase physical activity and promote a healthy diet in the local population. It also covers lifestyle weight management programmes for adults who are overweight or obese. It describes high-quality care in priority areas for improvement.
View quality statements for QS111Show all sections
Sections for QS111
- Introduction
- List of quality statements
- Quality statement 1: Vending machines
- Quality statement 2: Nutritional information at the point of choosing food and drink options
- Quality statement 3: Prominent placement of healthy options
- Quality statement 4: Maintaining details of local lifestyle weight management programmes
- Quality statement 5: Publishing performance data on local lifestyle weight management programmes
- Quality statement 6: Raising awareness of lifestyle weight management programmes
This guideline covers behaviours such as diet and physical activity to help children (after weaning), young people and adults maintain a healthy weight or help prevent excess weight gain. The aim is to prevent a range of diseases and conditions including cardiovascular disease and type 2 diabetes and improve mental wellbeing.
NICE has developed a medtech innovation briefing (MIB) on MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes
This project aimed to promote the implementation of NICE guidance PH38 utilising existing tier 2 and tier 3 weight management services, including commercial providers.
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)
NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes .
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes (IPG518)
Evidence-based recommendations on implantation of a duodenal-jejunal bypass liner for managing type 2 diabetes. This involves attaching a liner as a barrier between food and the upper part of the bowel, with the aim of lowering blood sugar levels.
Complications associated with diabetes Subject(s): Diabetes Date of publication: 27 May 2020
Evidence-based recommendations on dapagliflozin (Forxiga) for chronic kidney disease in adults.
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)
Evidence-based recommendations on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. This involves removing cells called islet cells, which are responsible for the production of insulin, from human donors.
View recommendations for IPG257Show all sections
Sections for IPG257
This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina. The guideline aims to improve survival and quality of life for people who have a heart attack or unstable angina.
Admission rates due to stroke in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
Admission rates due to angina in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
Admission rates due to myocardial infarction in people with diabetes
rates due to myocardial infarction in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
Admission rates due to diabetic ketoacidosis in people with diabetes
rates due to diabetic ketoacidosis in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
NICE indicators. NM51 diabetes guidance.
Admission rates for renal replacement therapy in people with diabetes
rates for renal replacement therapy in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
Admission rates due to heart failure in people with diabetes
Admission rates due to heart failure in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
This guideline covers how to encourage employees to be physically active. The aim is to increase the working population’s physical activity levels.
NICE indicators. NM28 diabetes guidance.
Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)
Evidence-based recommendations on dapagliflozin (Forxiga) for symptomatic chronic heart failure with reduced ejection fraction in adults.
Admission rates due to lower limb amputations in people with diabetes
rates due to lower limb amputations in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016
This quality standard covers treating and managing psychosis and schizophrenia in adults (aged 18 and over) in primary, secondary and community care. It also includes support for the families and carers of people with psychosis or schizophrenia. It describes high-quality care in priority areas for improvement.
View quality statements for QS80Show all sections
Sections for QS80
- Quality statements
- Quality statement 1: Referral to early intervention in psychosis services
- Quality statement 2: Cognitive behavioural therapy
- Quality statement 3: Family intervention
- Quality statement 4: Treatment with clozapine
- Quality statement 5: Supported employment programmes
- Quality statement 6: Assessing physical health
- Quality statement 7: Promoting healthy eating, physical activity and smoking cessation
Weight management: lifestyle services for overweight or obese adults (PH53)
This guideline covers multi-component lifestyle weight management services including programmes, courses, clubs or groups provided by the public, private and voluntary sector. The aim is to help people lose weight and become more physically active to reduce the risk of diseases associated with obesity. This includes coronary heart disease, stroke, type 2 diabetes and various cancers.
Myocardial infarction, stroke and stage 5 chronic kidney disease in people with diabetes
stage 5 chronic kidney disease in people with diabetes Subject(s): Diabetes, Kidney conditions, Stroke and ischaemic attack
Osteoporosis: assessing the risk of fragility fracture (CG146)
This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.
This guideline covers mid-life approaches to delay or prevent the onset of dementia, disability and frailty in later life. The guideline aims to increase the amount of time that people can be independent, healthy and active in later life.
NICE indicators. NM59 diabetes guidance.
patients with type 1 diabetes who are aged over 40 years currently treated with a statin Subject(s): Diabetes Date of
The proportion of adults with diabetes who have received all nine basic care processes.
proportion of adults with diabetes who have received all nine basic care processes. Subject(s): Diabetes
Community pharmacies: promoting health and wellbeing (NG102)
This guideline covers how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with a long-term condition. It aims to encourage more people to use community pharmacies by integrating them within existing health and care pathways and ensuring they offer standard services and a consistent approach. It requires a collaborative approach from individual pharmacies and their representatives, local authorities and other commissioners.
eligible people with diabetes who are offered an appointment for diabetic eye screening Subject(s): Diabetes Date
This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.
Number of people with diabetes with a single marker of all 9 basic care processes performed
of people with diabetes with a single marker of all 9 basic care processes performed Subject(s): Diabetes